Exploring anti-cancer activities of epidermal growth factor-immobilized polymeric nanoparticles
Cytotoxic agents targeting the epidermal growth factor receptor (EGFR) exhibit significant potential for cancer therapy as EGFR is overexpressed in various cancers. As alternatives to conventional EGFR inhibitors (EGFRi), which exert side effects on non-cancer cells, EGF-immobilized gold nanoparticl...
Saved in:
Main Authors: | Shota Yamamoto, Chia-Jung Chang, Masao Kamimura, Jun Nakanishi |
---|---|
Format: | Article |
Language: | English |
Published: |
Taylor & Francis Group
2025-02-01
|
Series: | Science and Technology of Advanced Materials |
Subjects: | |
Online Access: | https://www.tandfonline.com/doi/10.1080/14686996.2025.2463316 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Investigation of survival and prognostic factors in triple negative molecular subtype male breast cancer patients: A population-based study
by: Ahmet Necati Sanli, et al.
Published: (2024-04-01) -
RSL3 induces ferroptosis by activating the NF-κB signalling pathway to enhance the chemosensitivity of triple-negative breast cancer cells to paclitaxel
by: Jialin Yuan, et al.
Published: (2025-01-01) -
Recent advances in polymeric nanoparticles for the treatment of hepatic diseases
by: Feng Gao, et al.
Published: (2025-01-01) -
Sorafenib-Loaded Silica-Containing Redox Nanoparticle Decreases Tumorigenic Potential of Lewis Lung Carcinoma
by: Babita Shashni, et al.
Published: (2025-01-01) -
Giant triple negative pregnancy-associated breast cancer (PABC) in a young woman: From diagnosis to therapy step by step: A case report
by: Micol Bottalico, et al.
Published: (2025-03-01)